UNSPSC 51393104: Vesnarinone

This classification denotes a phosphodiesterase inhibitor and antineoplastic antibiotic with the molecular formula C22H25N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5COW40EV8M, chemically known as 3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1h)-quinolinone but generally known as vesnarinone, which bears US NIH Compound Identifier 5663. European Medicines Agency schedules Vesnarinone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00045MIG.

UNSPSC 51393104 Vesnarinone is a Commodity code representing pharmaceutical products procured by state and local health authorities. State and local governments use this code for purchases of specific medications and therapeutic agents to support public health programs, emergency response, and community health initiatives. The scope of work under this code includes the procurement and delivery of pharmaceutical products to support county health departments, community health centers, and emergency management operations.

State and local issuing bodies soliciting under this code include county health departments and public health authorities. Seminole County, Florida, posted an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through competitive bidding, with quarterly deliveries to the Seminole County Community Health Building at 520 W. Lake Mary Blvd, Sanford, Florida. The contract has an initial two-year term with a one-year renewal option, and vendors must comply with drug-free workplace certification, E-Verify requirements, and federal compliance obligations tied to FEMA funding. Recent activity centers on Florida, though the sparse opportunity record does not support a broad geographic characterization.